During the past decade, University of Utah - PPDS conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Utah - PPDS" are "COVID-19" (1 trials), "Colitis, Ulcerative" (1 trials) and "Duchenne Muscular Dystrophy" (1 trials). Many other conditions were trialed in "University of Utah - PPDS" in a lesser frequency.

Most popular intervention types in "University of Utah - PPDS" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Casimersen" (1 trials), "Golodirsen" (1 trials), "Ozanimod" (1 trials) and "Tocilizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Utah - PPDS" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Utah - PPDS". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in University of Utah - PPDS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Utah - PPDS, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".